Toshiba Medical systems' all-new Infinix 4DCT has received US FDA (United States Food and Drug Administration) clearance with the AquilionPRIME CT system configuration. The Infinix 4DCT previously received FDA clearance with the Infinix Elite cardiovascular X-ray system and Aquilion ONE ViSION Edition CT system configuration.

The system significantly improves workflow with its SUREGuidance technology, which allows for automatic transition between modalities. In addition, it is capable of saving significant time by allowing clinicians to perform CT and interventional procedures within the same room and verify treatment success following procedures.

"The Infinix 4DCT allows clinicians to plan, treat and verify in a single clinical setting, which negates the need to transfer patients between departments, resulting in anticipated decreases of both procedure time and risk of infection. This also contributes to improved patient safety and satisfaction by minimizing the clinicians' time spent away from patients, allowing them to focus on providing quality care," said Mr Bill Newsom, director, X-ray Vascular Business Unit, Toshiba.

Toshiba will showcase the Infinix 4DCT with the Aquilion PRIME CT at this year's American College of Cardiology (ACC).